Corebridge Financial’s 2seventy bio TSVT Stock Holding History

Corebridge Financial’s Portfolio TSVT Stock Details TSVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-23,943	Closed	-$118K	–	2595
2025 Q1	$118K	Sell	23,943 -356	-1%	-$1.13K	﹤0.01%	2361
2024 Q4	$71.4K	Sell	24,299 -1,834	-7%	-$7.52K	﹤0.01%	2714
2024 Q3	$123K	Sell	26,133 -161	-0.6%	-$726	﹤0.01%	2491
2024 Q2	$101K	Buy	+26,294	New	+$119K	﹤0.01%	2600

Other funds holding TSVT

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Corebridge Financial's TSVT Position: Q2 2025 in Review

Corebridge Financial sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 23,943 shares — an estimated $118K sold.

Corebridge Financial first reported a position in TSVT in Q2 2024 and held it in 4 quarters. The position peaked at $123K in Q3 2024. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

Corebridge Financial reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
Corebridge Financial sold 23,943 2seventy bio shares in Q2 2025, an estimated $118K.
Corebridge Financial first reported a position in 2seventy bio in Q2 2024 and held it in 4 quarters.
Corebridge Financial's 2seventy bio position peaked at $123K in Q3 2024.
2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.